CERS
Cerus Corp.

4,398
Mkt Cap
$311.18M
Volume
1.03M
52W High
$2.24
52W Low
$1.12
PE Ratio
-19.13
CERS Fundamentals
Price
$1.62
Prev Close
$1.60
Open
$1.54
50D MA
$1.50
Beta
1.89
Avg. Volume
1.22M
EPS (Annual)
-$0.1133
P/B
5.06
Rev/Employee
$641,530.25
Loading...
Loading...
News
all
press releases
Cerus (NASDAQ:CERS) Raised to Buy at Wall Street Zen
Wall Street Zen upgraded Cerus from a "hold" rating to a "buy" rating in a report on Saturday...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
Cerus (NASDAQ:CERS) Announces Quarterly Earnings Results
Cerus (NASDAQ:CERS - Get Free Report) announced its quarterly earnings results on Thursday. The biotechnology company reported $0.00 earnings per share for the quarter, beating the consensus estimate...
MarketBeat·9d ago
News Placeholder
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
Cerus Corporation (Nasdaq: CERS) announced today financial results for the third quarter ended September 30, 2025, and provided a business update. We continue to make great strides in improving the...
Business Wire·10d ago
News Placeholder
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting
Cerus Corporation (Nasdaq: CERS) announced today that it will host an industry workshop on the benefits of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, commonly referred to as INTERCEPT...
Business Wire·26d ago
News Placeholder
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025
Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the close of the stock market. The Company will...
Business Wire·1mo ago
News Placeholder
Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results
Cerus Corporation (Nasdaq: CERS) today announced financial results for its full year and fourth quarter ended December 31, 2024. Recent highlights include: Total revenue for full-year 2024 and fourth...
Business Wire·9mo ago
News Placeholder
Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference
Cerus Corporation (Nasdaq: CERS) announced today that members of Cerus management are scheduled to present at the TD Cowen 45th Annual Health Care Conference on Wednesday, March 5, at 11:10 a.m. EST...
Business Wire·9mo ago
News Placeholder
Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025
Cerus Corporation (Nasdaq: CERS) announced today that its fourth quarter and full-year 2024 financial results will be released on Thursday, February 20, 2025, after the close of the stock market. The...
Business Wire·9mo ago
News Placeholder
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update
Cerus Corporation (Nasdaq: CERS) today announced preliminary product revenue for the fourth quarter and full-year 2024 and provided product revenue guidance for full-year 2025. The Company expects...
Business Wire·10mo ago
News Placeholder
Cerus Corporation to Participate in Upcoming Investor Conferences
Cerus Corporation (Nasdaq: CERS) announced management participation in two upcoming investor conferences. Management plans to participate in the Stifel 2024 Healthcare Conference on Monday, November...
Business Wire·1y ago

Latest CERS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.